Outlook Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $13k | 8.3k | 1.60 |
| 2025-03-31 | $11k | 8.7k | 1.22 |
| 2024-12-31 | $12k | 6.4k | 1.89 |
| 2024-09-30 | $10k | 2.0k | 5.34 |
| 2024-06-30 | $18k | 2.4k | 7.38 |
| 2024-03-31 | $6.1k | 510 | 11.94 |